Background
==========

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide \[[@B1]\]. It presents exacerbations that often lead the patient to the Emergency Department (ED) and to hospitalization, contributing significantly to higher health care costs \[[@B2]\]. In Spain, COPD prevalence in adults aged 40-69 is 9.1% \[[@B3]\]. The disease ranks fourth among causes of mortality \[[@B4]\] and it is responsible for 7% of hospital admissions \[[@B5]\]. COPD-related costs in 1998 were estimated at about € 1,210 million \[[@B6]\].

Despite the large economic impact posed by COPD exacerbations, there is a still ongoing debate about the predictors of higher likelihood of hospitalization in patients with COPD exacerbation which have received hospital care in an ED \[[@B7]-[@B9]\].

Latest studies have shown a significant increase in hospital admissions for chronic obstructive respiratory disease in recent years in our region \[[@B10]\].

The aim of this study was to determine the frequency of COPD exacerbations in our ED, as well as the hospitalization-related factors.

Methods
=======

This is a prospective observational study conducted in the ED of Salnés County Hospital, a 100-bed facility providing health coverage to 80,000 people , for one year (from March 1, 2009 to February 28, 2010), among patients admitted for COPD exacerbations. Included in the study there were patients with a COPD diagnosis confirmed by a doctor, and those patients with consistent clinical, radiological and epidemiological manifestations , typical symptoms, and smoking history greater than 10 pack years. The information was obtained from medical records and by interviewing patients during their stay in the ED. COPD severity was determined on the basis of the GOLD guidelines \[[@B11]\]. COPD exacerbation was defined as the sustained worsening of the patient's condition, from the stable state and beyond the normal day-to-day variations, that is acute in onset and necessitates a change in regular medication in a patient with underlying COPD \[[@B12]\]. Hospital admission was defined as admission to inpatient unit, observation unit, or intensive care unit after receiving the first care in the ED \[[@B8]\].

The following variables were analyzed:

1\. Patient characteristics: age, gender, years of COPD evolution, that is the time elapsed from the COPD diagnosis or from the start of compatible symptoms referred by the patient till the moment of inclusion in the study; smoking status, categorized as "never smoker", "active smoker", "passive smoker" and "former smoker"; comorbidities; employment status, employed, unemployed, retired; reason for retirement, age, COPD, other diseases, and social support.

2\. Characteristics of the underlying disease: COPD severity \[[@B11]\], patient regular treatment, previous treatment with systemic steroids, oxygen therapy at home, ED care and hospital admissions in the year before and in the year when the patient was enrolled in the study.

3\. Data of current exacerbation: O~2~ saturation measured by pulse oximetry and vital signs, considering systolic hypotension SBP \< 100 mm Hg, diastolic hypotension DBP \< 60 mm Hg and tachycardia heart rate \> 100 \[[@B13],[@B14]\]. Baseline oxygenation was stratified into two categories based on SaO~2~/FiO~2~ ratio, setting the cut off value at 90% saturation breathing room air, which corresponds to a value of 428.6. The analytical parameters included (hemoglobin, leukocytosis, neutrophilia and urea) were stratified into three categories: normal, high, low , according to the reference values in our medical laboratory. With regard to severity of the episode, the priority of care was based on the MTS (Manchester Triage System), which classifies the patient into five categories, enabling care prioritization according to patient severity: 1 = immediate: immediate attention; 2 = very urgent: care delayed up to 10 minutes; 3 = urgent: 60 minutes; 4 = standard: 120 minutes; 5 = non-urgent: 240 minutes \[[@B15]\].

4\. Treatments provided in the ED, and finally.

5\. Data on the evolution of the exacerbation: length of stay in ED, patient destination, discharge or admission criteria.

Statistical analysis
--------------------

The variables included in the study were analyzed on the basis of hospital admission for COPD exacerbation. Fisher's exact test and Chi-square test were used to compare categorical variables. T-Student test was used to analyze continuous variables following normal distribution, as well as Levene test to verify the homogeneity of the variances. Mann-Whitney U-test was used for non-Gaussian distributions.

Likelihood of hospitalization was estimated by multivariate logistic regression, including in the analysis those variables that showed differences between patients admitted and not admitted with *p* \< 0.1. All data were analyzed with SPSS 15 for Windows.

Results and discussion
======================

In the year of study, 409 exacerbations were registered in 239 patients (representing 1.07% of all emergencies treated), with a rate of 1.12 episodes-day. 69% of patients came only once to the hospital. 79% out of 239 patients were male. The mean age was 75 years (ranging 41-96, SD 9.51). 57% out of all exacerbations required admission. 11% out of all admissions were done in home care regime. Only one case required admission to the Intensive Care Unit (ICU). The admission decision was based on exacerbation severity as per clinical and analytical criteria in 61 patients, and the presence of decompensated comorbidity in 81 cases. The most frequent discharge reasons were mild COPD exacerbation or absence of respiratory failure after arterial blood gas measurement (data not shown). Univariate analysis revealed a higher frequency of hospital admissions in the following cases: those of highest priority for initial care according to the Manchester Scale (Types 1 and 2 account for most admissions); those with impaired oxygenation, higher respiratory effort, or requiring O~2~ administration; those receiving bronchodilator or steroid treatment in the ED; and those with respiratory-infection related COPD exacerbation, with longer ED stays, or with a history of COPD-exacerbation related admissions (Table [1](#T1){ref-type="table"}). Hospitalization-related factors in multivariate analysis were impaired oxygenation, presence of neutrophilia and administration of antibiotics in the ED (Table [2](#T2){ref-type="table"}).

###### 

Demographic and clinical characteristics of patients assessed by the ED for COPD exacerbation, sorted by hospital admission

  **Predictors**                                                            **N**      **Not admitted**   **Admitted**     p
  --------------------------------------------------------------------- ------------- ------------------ -------------- --------
  Gender                                                                                                                    
   Male                                                                  188 (78.7%)      78 (41.5%)      110 (58.5%)      NS
   Female                                                                51 (21.3%)       22 (43.1%)       29 (56.9%)       
  Age                                                                                                                       
   \< 65 years                                                           37 (15.5%)       16 (43.2%)       21 (56.8%)      NS
   65-75 years                                                           74 (31.1%)       30 (40.5%)       44 (59.5%)       
   \>75 years                                                            127 (53.4%)      54 (42.5%)       73 (57.5%)       
  Manchester                                                                                                                
   1 and 2                                                               98 (41.17%)      24 (24.5%)       74 (75.5%)    \*\*\*
   3                                                                     100 (42.0%)      44 (43.6%)       56(56.4%)        
   4 and 5                                                               40 (16.8%)       32 (80.0%)       8 (20.0%)        
  Gold                                                                                                                      
   0                                                                     102 (42.7%)      52 (51.0%)       50 (49.0%)      \*
   1 and 2                                                               61 (25.5%)       26 (42.6%)       35 (57.4%)       
   3 and 4                                                               76 (31.8%)       22 (28.9%)       54 (71.1%)       
  Smoker                                                                                                                    
   No                                                                    50 (23.0%)       24 (48.0%)       26 (52.0%)      NS
   Yes                                                                   34 (15.7%)       16 (47.1%)       18 (52.9%)       
   Former smoker                                                         130 (59.9%)      51 (39.2%)       79 (60.8%)       
   Passive smoker                                                         3 (1.4%)        1 (33.3%)        2 (66.7%)        
  Tachypnea                                                                                                                 
   No                                                                    149 (62.3%)      76 (51.0%)       73 (49.0%)    \*\*\*
   Yes                                                                   90 (37.7%)       24 (26.7%)       66 (73.3%)       
  SBP                                                                                                                       
   \< 100                                                                 5 (2.1%)        2 (40.0%)        3 (60.0%)       NS
   100-140                                                               110 (46.2%)      47 (42.7%)       63 (57.3%)       
   \>140                                                                 123 (51.7%)      51 (41.5%)       72 (58.5%)       
  DBP                                                                                                                       
   \<60                                                                  31 (13.5%)       11 (35.5%)       20 (64.5%)      NS
   60-90                                                                 174 (76.0%)      77 (44.3%)       97 (55.4%)       
   \>90                                                                   24(10.5%)       12 (35.3%)       22 (64.7%)       
  T^a^                                                                                                                      
   \<37°C                                                                172 (72.0%)      79 (45.9%)       93 (54.1%)      \*
   \>37C                                                                 67 (28.0%)       21 (31.3%)       46 (68.7%)       
  HR                                                                                                                        
   \<100                                                                 156 (65.5%)      74 (47.4%)       82 (56.2%)      \*
   \>100                                                                 82 (34.5%)       25 (30.5%)       57 (69.5%)       
  SaO~2~/FiO~2~                                                                                                             
   \<428.6                                                               84 (35.1%)        8 (9.5%)        76 (90.5%)    \*\*\*
   \>428.6                                                               155 (64.9%)      92(59.4%)        63 (40.6%)       
  O~2~ at Home                                                                                                              
   No                                                                    196 (82.0%)      85 (43.4%)      111 (56.6%)      NS
   Yes                                                                   43 (18.0%)       15 (34.9%)       28 (65.1%)       
  Baseline Treatment                                                                                                        
   Oral Corticosteroids                                                   16 (6.7%)       6 (37.5%)        10 (62.5%)      NS
   Anticholinergics and/or saba and/or laba                              26 (11.3%)       8 (30.8%)        18 (69.2%)       
   Anticholinergics and/or saba and/or laba + Inhaled Corticosteroids    140 (58.3%)      63 (45.0%)       77 (55.0%)       
   None of these (ALT, Theophylline..)                                   55 (22.9%)       23 (41.8%)       32 (58.2%)       
  ED Treatment                                                                                                              
   Antibiotics                                                                                                              
    No                                                                   102 (43.4%)      61 (59.8%)       41 (40.2%)    \*\*\*
    Yes                                                                  133 (56.6%)      39 (29.3%)       94 (70.7%)       
  O~2~                                                                                                                      
    No                                                                   26 (11.1%)       23 (88.5%)       3 (11.5%)     \*\*\*
    Yes                                                                  209 (88.9%)      77 (36.8%)      132 (63.2%)       
  Systemic Corticosteroids                                                                                                  
    No                                                                   64 (27.2%)       40 (62.5%)       24 (37.5%)    \*\*\*
    Yes                                                                  171 (72.8%)      60 (35.1%)      111 (64.9%)       
  Inhaled/Nebulized Cortocosteroids                                                                                         
    No                                                                   183 (76.6%)      85 (46.4%)       98 (53.6%)     \*\*
    Yes                                                                  56 (23.4%)       15(26.8%)        41 (73.2%)       
  Any Nebulized Drugs                                                                                                       
    No                                                                   44 (18.4%)       22 (50.0%)       22 (50.0%)      NS
    Yes                                                                  195 (81.6%)       78 (40%)        117 (60%)        
  Beta-agonists                                                                                                             
    No                                                                   39 (16.3%)       24 (61.5%)       15 (38.5%)     \*\*
    Yes                                                                  200 (83.7%)      76 (38.0%)      124 (62.0%)       
  Anticholinergics                                                                                                          
    No                                                                   40 (17.1%)       23 (57.5%)       17 (42.5%)      \*
    Yes                                                                  194 (82.9%)      77 (39.7%)      117 (60.3%)       
  Anti-Leukotrienes                                                                                                         
    No                                                                   232 (98.7%)     100( 43.1%)      132 (56.9%)      NS
    Yes                                                                   3 (1.3%)         0 (0.0%)         3 (100%)        
  Theophyllines                                                                                                             
    No                                                                   231 (98.3%)      99 (42.9%)      132 (57.1%)      NS
    Yes                                                                   4 (1.7%)        1 (25.0%)        3 (75.0%)        
  Mucolytics                                                                                                                
    No                                                                   206 (87.7%)      87 (42.2%)      119 (57.8%)      NS
    Yes                                                                   29(12.3%)       13 (44.8%)       16 (55.2%)       
  Month                                                                                                                     
    January-March                                                        78 (32.6%)       33 (42.3%)       45 (57.7%)      NS
    April-June                                                           59 (24.7%)       23 (39.0%)       36 (61.0%)       
    July-September                                                       52 (21.8%)       23 (44.2%)       29 (55.8%)       
    October-December                                                     50 (20.9%)       21 (42.0%)       29 (58.0%)       
  Day of the Week                                                                                                           
    Monday-Thursday                                                      150 (62.8%)      62 (41.3%)       88 (58.7%)      NS
    Friday-Sunday                                                        89 (37.2%)       38 (42.7%)       51 (57.3%)       
  Time                                                                                                                      
    0-8:00                                                               38 (15.9%)       12 (31.6%)       26 (68.4%)      NS
    8:00-16:00                                                           113 (47.3%)      48 (42.5%)       65 (57.5%)       
    16:00-24:00                                                          88 (36.8%)       40 (45.5%)       48 (54.5%)       
  Hospital Readmissions                                                                                                     
    None                                                                 201 (84.1%)      90 (44.8%)       111(55.2%)      \*
    Any (Early or Late)                                                  38 (15.9%)       10 (26.3%)       28 (73.7%)       
  ED Readmissions                                                                                                           
    None                                                                 228 (95.4%)      96 (42.1%)      132 (57.9%)      NS
    Any (Early or Late)                                                   11 (4.6%)       4 (36.4%)        7 (63.6%)        
  Number of Admissions                                                                                                      
    None                                                                 82 (34.3%)       79 (96.3%)        3 (3.7%)     \*\*\*
    One                                                                  120 (50.2%)      12 (10.0%)      108 (90.0%)       
    Two or More                                                          37 (15.5%)       9 (24.3%)        28 (75.7%)       
  Number of Emergencies                                                                                                     
    One                                                                  166 (69.5%)      64 (38.6%)      102 (61.4%)      NS
    Two                                                                  33 (13.8%)       16 (48.5%)       17 (51.5%)       
    Three or More                                                        40 (16.7%)       20 (50.0%)       20 (50.0%)       
  Length of the Crisis (Hours)                                                                                              
    \< 12                                                                23 (10.8%)       9 (39.1%)        14 (60.9%)      NS
    12-24                                                                35 (16.4%)       10 (28.6%)       25 (71.4%)       
    24-72                                                                29 (13.6%)       11 (37.9%)       18 (62.1%)       
    \>72                                                                 126 (59.2%)      58 (46.0%)       68 (54.0%)       
  Length of ED Stay (Hours)                                                                                                 
    \< 4                                                                 63 (27.8%)       38 (60.3%)       25 (39.7%)    \*\*\*
    4-8                                                                  50 (22.0%)       23 (46.0%)       27 (54.0%)       
    8-18                                                                 58 (25.5%)       20 (34.5%)       38 (65.5%)       
    \>72                                                                 126 (24.7%)      11 (19.6%)       45 (80.4%)       
  Hemoglobin                                                                                                                
    Low                                                                  106 (44.7%)      46 (43.4%)       60 (56.6%)      NS
    Normal                                                                128 (54%)       52 (40.6%)       76 (59.4%)       
    High                                                                  3 (1.3%)         0 (0.0%)        3 (100.0%)       
  Leukocytes                                                                                                                
    Leukopenia                                                            5 (2.1%)        3 (60.0%)        2 (40.0%)     \*\*\*
    Normal                                                               154 (64.4%)      79 (51.3%)       75 (48.7%)       
    Leukocytosis                                                         80 (33.5%)       18 (22.5%)       62 (77.5%)       
  Neutrophil count                                                                                                          
    Low                                                                   3 (1.3%)        1 (33.3%)        2 (66.7%)     \*\*\*
    Normal                                                               127 (53.1%)      69 (54.3%)       58 (45.7%)       
    High                                                                 109 (45.6%)      30 (27.5%)       79 (72.5%)       
  Urea                                                                                                                      
    Low                                                                   4 (1.8%)        2 (50.0%)        2 (50.0%)       NS
    Normal                                                               120 (52.6%)       54 (45%)        66(55.0%)        
    High                                                                 104 (45.6%)      33 (31.7%)       71 (68.3%)       
  Emergencies the Year Before                                                                                               
    None                                                                 150 (62.7%)      59 (39.3%)       91 (60.7%)      NS
    One                                                                  37 (15.5%)       19 (51.4%)       18 (48.6%)       
    Two or More                                                          52 (21.8%)       22 (42.3%)       30 (57.7%)       
  Hospital Admissions the Year Before                                                                                       
    None                                                                 178 (75.1%)      75 (42.1%)      103 (57.9%)      NS
    One                                                                  37 (15.6%)       16 (43.2%)       21 (56.8%)       
    Two or More                                                           22 (9.3%)       7 (31.8%)        15 (68.2%)       

\**p* \< 0.05.

\*\**p* \< 0.01.

\*\*\* *p* \< 0.001. NS = not significant.

###### 

Predictors of hospital admission according to multivariate analysis

  **Factors**                **OR**     **CI 95%**     **p**
  ------------------------- -------- ---------------- --------
  Neutrophilia                3.15    (1.570, 6.335)    \*\*
  SaO~2~/ FiO~2~ \> 428.6    0.080    (0.034, 0.187)   \*\*\*
  Antibiotics                2.175    (1.081, 4.376)     \*

\**p* \< 0.05.

\*\**p* \< 0.01.

\*\*\* *p* \< 0.001.

Exacerbations are a fundamental aspect of COPD-generated costs \[[@B16]\]. The decision to admit a patient with COPD exacerbation is based on the interpretation of a series of clinical data, such as severity of dyspnea, respiratory failure, poor response to treatment during the stay in the ED, and presence of pneumonia or other comorbidities \[[@B17]\]. In our patients, as in other studies, the decompensation of underlying diseases is a frequent cause of hospitalization \[[@B18]\]. Determinants of hospital admission in COPD exacerbations in our environment depend mainly on some characteristics of the exacerbation, such as impaired oxygenation and the presence of neutrophilia. The other factor which proved to be an independent predictor of hospital admission was the decision to administer antibiotics by the ED, which also depends - at least in part - on the exacerbation severity determined by the MD in charge.

Respiratory failure is one of the criteria that lead to the decision to grant hospital admission, together with exacerbation severity and even the need for mechanical ventilation in patients with COPD exacerbations \[[@B19]\].

In our study, oxygenation - assessed by the SaO~2~/FiO~2~ ratio - was lower in patients who were admitted, indicating the severity of the exacerbation or of the underlying disease \[[@B19]\].

Given its simplicity, pulse oximetry seems to be a particularly useful method to assess oxygenation in patients with COPD exacerbation: it does not require special training, is reliable in the range of 80-100% saturation and, although it is not a substitute for blood gas measurement, it provides real time, continuous and non-invasive monitoring of heart rate, can alert on tissue perfusion decreases \[[@B20]\], and detect hypoxia with high sensitivity and specificity \[[@B21]\].

Although pulse oximetry provides guidance on the initial need for oxygen therapy, arterial blood gas measurement is essential to assess potential hypercapnia and acidosis \[[@B11]\].

Inflammatory markers could also be used as a parameter to assess the severity of COPD exacerbations \[[@B22]\]. One of the systemic markers of inflammation is the neutrophil count in peripheral blood, which is higher in bacterial exacerbations \[[@B23]\]. Some authors report significant relationship between neutrophilia in peripheral blood, exacerbation severity and hospital admission frequency in COPD exacerbations \[[@B24],[@B25]\]. In our case, neutrophil count in peripheral blood was significantly higher among those admitted, so neutrophilia could be a particularly important indicator in the initial exacerbation assessment in those patients.

The causes of exacerbations are not always known and, in connection with the latter, also the optimal treatment, that should logically be different according to exacerbation etiology. In our study, the initial decision by the ED doctor to start an antibiotic treatment appears to be associated with a higher likelihood of hospital admission, regardless of both patient baseline and exacerbation severity. Since the indication of antibiotic treatment in COPD exacerbations is not clearly established \[[@B26]-[@B28]\], this decision could be based on clinical criteria \[[@B29]\], and even in those cases where the likelihood of bacterial infectious etiology is not evident, some doctors may consider antibiotic prescription to be safer \[[@B28]\].

Antibiotic treatment seems to be beneficial in most severe exacerbations and in those cases with high clinical likelihood of infection \[[@B30]-[@B32]\]. Also, antibiotic prescription in COPD exacerbations which require hospital admission is widespread \[[@B26]\]. These facts may condition the prescription of antibiotic treatment in the ED to change the perception of COPD exacerbation severity by the doctors who eventually request patient admission, regardless of objective criteria: the start of antibiotic treatment in the ED means to increase the likelihood of hospital admission by more than twice.

Conclusions
===========

In conclusion, COPD exacerbations account for over 1% of all visits to our ED, 57% of which will require hospitalization. Impaired oxygenation, higher peripheral blood neutrophilia and antibiotic prescription in the ED are associated with a greater likelihood of hospitalization in COPD exacerbations assessed in the ED.
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